Altria Group Inc vs Starbucks Corp — how do they compare? Altria Group Inc trades at $64.61 (market cap $108.58B), while Starbucks Corp trades at $106.57 (market cap $121.59B). The key difference: Altria Group Inc and Starbucks Corp are close in size by market cap, and Altria Group Inc pays the higher dividend (6.52%). Which is the better fit depends on your goals.
| MO | SBUX | |
|---|---|---|
Market Cap | $108.58B | $121.59B |
Sector | Consumer Staples | Consumer Cyclical |
52-Week High | $74.92 | $108.37 |
52-Week Low | $54.72 | $78.46 |
Enterprise Value | $130.79B | $140.42B |
Dividend Yield | 6.52% | 2.33% |
Volume | — | 7,493,833 |
Signals from Pluang's Aura AI — not financial advice
Altria Group (MO) trades at $65.54, down 4.11% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with a 39% net income margin and attractive 6.3% dividend yield, though cigarette volume declines persist. Recent Q2 2026 earnings missed expectations, triggering price weakness and multiple legal investigations into potential securities violations. Analyst consensus remains positive with 61.5% buy ratings and $67 price target, but technical indicators suggest near-term pressure with support at $62-65.
MO presents a value opportunity for income investors with its high yield and reasonable P/E of 13.7, though regulatory risks and declining traditional tobacco business create headwinds. The smoke-free product expansion offers growth potential, but legal uncertainties and volume erosion require careful monitoring. Current levels near support provide entry points for dividend-focused investors willing to accept sector-specific risks.
Starbucks (SBUX) trades at $104.65, down 0.88% on the day, with technical indicators neutral and support near $104. The company reported mixed quarterly EPS results, beating in Q1 and Q2 2026 but missing in Q4 2025, while raising its fiscal 2026 outlook. Revenue grew to $37.18B in 2025, but net income fell to $1.86B, compressing margins. Analyst consensus is a Buy with a $113.60 price target, citing a traffic recovery and cost initiatives.
The outlook hinges on sustaining sales momentum and margin expansion amid high valuation multiples. Risks include execution on turnaround plans, competitive pressure, and debt levels. Upside potential exists if earnings recovery continues, but investors face volatility from macroeconomic headwinds and premium pricing.
Trailing returns across standard periods
Latest headlines on both assets
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →